Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04670575 · ClinicalTrials.gov registry record
Vivity Outcomes in Patients With Early Stage Glaucoma
A clinical trial, sponsored by Vance Thompson Vision.
- Completed
- Registry status
- 27
- Enrollment target
NCT04670575 is a clinical trial that has completed, run by Vance Thompson Vision. The registered enrollment target is 27 participants.
The verdict
NCT04670575 has completed, sponsored by Vance Thompson Vision.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
Study Summary
The goal of the study is to determine the visual outcomes in patients with mild, pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular Lens (IOL).
Interventions
- PROCEDURE Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2021-01-01 |
| Est. Completion | 2022-11-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04670575
The ClinicalTrials.gov registry entry for NCT04670575 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 27 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vance Thompson Vision, which has 14 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL is the first listed.
NCT04670575 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04670575 about?
NCT04670575 is a clinical study titled "Vivity Outcomes in Patients With Early Stage Glaucoma". The goal of the study is to determine the visual outcomes in patients with mild, pre-perimetric glaucoma who undergo cataract surgery with implantation of the Alcon Vivity Extended Range Intraocular Lens (IOL).
What is the current status of trial NCT04670575?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2021-01-01. Estimated completion is 2022-11-30.
What interventions are being tested in trial NCT04670575?
The interventions under investigation include: Cataract Surgery with Implantation of Vivity Extended Range of Vision IOL (PROCEDURE).
Who is sponsoring clinical trial NCT04670575?
This trial is sponsored by Vance Thompson Vision, which has 14 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.